Aptar Pharma, a manufacturer of nasal and pulmonary drug delivery devices, has launched Twister, a new capsule-based Dry Powder Inhaler (DPI) for asthma sufferers.
Twister is a transparent device that operates by three simple steps: Insert, Twist and Inhale.
Aptar Pharma Prescription Division Business Development associate director Adam M. Shain said Twister complements the company's fully comprehensive range of drug delivery solutions, available worldwide for the pharmaceutical industry's treatment of Asthma and COPD.
"With the launch of Twister?, Aptar Pharma is set to fulfill regional needs for a simpler and well suited solution to deliver powder to the lungs," Shain added.
Aptar Pharma develops drug delivery systems that meet the evolving needs of biotechnology, healthcare and pharmaceutical companies.
